Your Location:
Home >
Browse articles >
Zuogui Jiangtang Shuxin Prescription Ameliorates Lipid Deposition in Diabetic Cardiomyopathy of MKR Mice by Regulating AMPK/FoxO1/CD36 Signaling Pathway
Zuogui Jiangtang Shuxin Prescription Ameliorates Lipid Deposition in Diabetic Cardiomyopathy of MKR Mice by Regulating AMPK/FoxO1/CD36 Signaling Pathway
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 32, Issue 10, Pages: 134-142(2026)
DOI: 10.13422/j.cnki.syfjx.20252506
Revised:2025-12-26 ,
Accepted:26 December 2025
Scan QR Code
AI Introduction
Full Text(HTML)
Figs( 4 ) Tabs( 7 )
References
Publication Info
Metrics
237
Views
172
Downloads
0
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Astragali Radix and Its Formulas in Treatment of Diabetic Cardiomyopathy: A Review
Syndrome Differentiation and Treatment Mechanisms of Inflammatory Injury in Diabetic Cardiomypathy from Theory of "Gaozhuo"
Mechanism Investigation of Qi-invigorating and Blood-activating Drug Combination in Yitangkang Compound Against Diabetic Cardiomyopathy Using Multimodal Research Approach
Treatment of Diabetic Cardiomyopathy with Shengmaisan-like Formulae: A Review
Discussion on Modern Development of Traditional Chinese Medicine Diagnosis Based on Artificial Intelligence
Related Author
CUI Ran
ZHU Linping
YAN Jingshun
ZHANG Pingting
XIE Chuxuan
LIU Yansong
ZHAO Mei
LI Yuhong
Related Institution
State Key Laboratory of Component-based Chinese Medicine, Institute of TCM, Tianjin University of TCM
First Teaching Hospital of Tianjin University of TCM
The Second Affiliated Hospital of Tianjin University of TCM
Graduate School, Tianjin University of Traditional Chinese Medicine(TCM)
The First School of Clinical Medicine, Hunan University of Chinese Medicine


